ADJUVANT TREATMENT OF GASTRIC CANCER

Leonardo Villacres Montesdeoca; Giadira Espinosa Sanchez; Karen Chavez Cadena; Pablo Llerena Jara; Jessica Romero Mazon; Mary Acuna; Jonathan Freire Sosa; Anita Segovia

Volume : VIII, Issue : VI, June - 2019

ADJUVANT TREATMENT OF GASTRIC CANCER

Leonardo Villacres Montesdeoca, Giadira Espinosa Sanchez, Karen Chavez Cadena, Pablo Llerena Jara, Jessica Romero Mazon, Mary Acuna, Jonathan Freire Sosa, Anita Segovia

Abstract :

OBJECTIVE: To determine the overall survival time in patients treated with adjuvant chemoradiotherapy. METHODS: patients diagnosed with gastric adenocarcinoma or gastroesophageal junction who received adjuvant chemoradiotherapy during the years 2011 to 2015, survival was analyzed using Chi–square test and survival curves of Kaplan Meier. RESULTS: 197 individuals were included in the analysis, of whom 115 were men (58.4%) and 82 women (41.6%); with ages between 18 and 89 years, distributed in clinical stages IB to IIIC, showing an average of overall survival of 51.5 months with a Log Rank of 2.98; 95% CI (45.7 – 57.4) with a general survival of up to 90 months. CONCLUSION: the study showed a greater overall survival than the data reported in the Intergroup 0116 and ARTIST study.